Close
ACHEMA MIDDLE EAST 2026

Emerging Trends Reshaping The Pharmaceutical Supply Chain

The pharma sector happens to be consistently evolving, and one of the most critical components of transformation is within the supply chain. The significance...

UK Boosts Life Sciences Sector With £650 Million Funding

The UK chancellor has gone on to announce a £650 million growth package in life sciences so as to help in delivering the science...

WHO And Korea Sign MoU For Biomanufacturing Training Hub

The World Health Organisation as well as the Republic of South Korea have gone ahead and inked a MoU so as to establish a...

Chinese Market Regulator Fines Two Monopolistic Pharma Firms

Two pharmaceutical companies for monopolistic behaviour have been penalized by the Chinese regulator. It has put a fine on Grand Pharmaceuticals for 136 million...

Enhancing Patient Care In The UK Through Recognition Routes

The medicines and healthcare products regulatory agency has gone on to announce that the new global regulatory recognition routes for drugs will be established...

Battling Global Medicine Shortages With EMA Recommendations

The European Medicines Agency has published recommendations to tackle medicine shortages and their associated repercussions. These recommendations emphasize the importance of ensuring the availability...

Machine Learning – A Game-Changer In The Pharma Industry

Machine learning, when it comes to the pharma sector, had a value of almost $1.2 billion in 2021, and it is anticipated to touch...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...